Starpharma Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Starpharma Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Starpharma Holdings's Price has increased by 100.00%, going from $0.00 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $0.00 – an increase of 100.00%. The Starpharma Holdings forecast is for Fair Value to reach $0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CSL Stock Forecast | CSL | Outperform |
12
|
$279.56 | Buy/Sell | $205.51 | -27.33% |
| TLX Stock Forecast | Telix Pharmaceuticals | Buy |
6
|
$14.97 | Buy/Sell | $13.37 | -3.14% |
| NEU Stock Forecast | Neuren Pharmaceuticals | Buy |
11
|
$20.25 | Buy/Sell | $26.43 | 31.26% |
| PNV Stock Forecast | PolyNovo | Outperform |
8
|
$2.12 | Buy/Sell | $1.88 | 0.94% |
| CUV Stock Forecast | Clinuvel Pharmaceuticals | Buy |
16
|
$15.39 | Buy/Sell | $27.41 | 44.57% |
Starpharma Holdings Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Starpharma Holdings's Revenue has decreased from $6.56M to $4.21M – a 35.82% drop! In the next year, analysts are expecting an increase in Revenue, predicting it will reach $6.59M – an increase of 56.45%. The Starpharma Holdings forecast is for Revenue to reach $5.39M or grow by 28.14%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IMU Stock Forecast | Imugene | Buy |
4
|
$0.08 | Buy/Sell | $0.35 | 425.00% |
| IMM Stock Forecast | Immutep | Buy |
8
|
$0.49 | Buy/Sell | $1.26 | 104.08% |
| OPT Stock Forecast | Opthea | Hold |
10
|
$0.65 | Buy/Sell | $1.15 | 7.69% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MSB Stock Forecast | Mesoblast | Buy |
9
|
$1.18 | Buy/Sell | $0.69 | -6.78% |
| PYC Stock Forecast | PYC Therapeutics | Buy |
8
|
$0.11 | Buy/Sell | $0.30 | 227.27% |
| CGS Stock Forecast | Cogstate | Buy |
11
|
$1.41 | Buy/Sell | $1.85 | 27.66% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BOT Stock Forecast | Botanix Pharmaceuticals | - |
0
|
$0.19 | Buy/Sell | $0.00 | -100.00% |
| DXB Stock Forecast | Dimerix |
0
|
$0.35 | Buy/Sell | $0.00 | 65.71% | |
| ACW Stock Forecast | Actinogen Medical |
5
|
$0.03 | Buy/Sell | $0.15 | -100.00% |
Starpharma Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Starpharma Holdings's EBITDA has grown, increasing from $-14.96M to $-15.38M – a growth of 2.81%. The next year looks promising for Starpharma Holdings, with analysts predicting EBITDA of $-15.70M – an increase of 2.07%. Over the next seven years, experts anticipate that Starpharma Holdings's EBITDA will grow at a rate of 8.39%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIT Stock Forecast | Biotron | - |
0
|
$0.06 | Buy/Sell | $0.00 | -100.00% |
| IVX Stock Forecast | Invion | - |
0
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| PTX Stock Forecast | Prescient Therapeutics |
2
|
$0.05 | Buy/Sell | $0.20 | 180.00% |
Starpharma Holdings EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Starpharma Holdings's EBIT has grown by 3.48%, from $-15.24M to $-15.77M. For the next year, analysts are expecting EBIT to reach $-16.04M – an increase of 1.73%. Over the next seven years, experts predict that EBIT will grow by 7.87%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CYP Stock Forecast | Cynata Therapeutics |
0
|
$0.24 | Buy/Sell | $1.24 | 416.67% | |
| 1AI Stock Forecast | Algorae Pharmaceuticals | - |
-4
|
$0.01 | Buy/Sell | $0.00 | -100.00% |
| IMC Stock Forecast | Immuron | - |
0
|
$0.07 | Buy/Sell | $0.00 | -100.00% |
Starpharma Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Starpharma Holdings's EPS has increased by 100.00%, going from $-0.04 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $0.00 – an increase of 100.00%. The Starpharma Holdings forecast is for EPS to reach $0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATH Stock Forecast | Alterity Therapeutics | - |
0
|
$0.00 | Buy/Sell | $0.75 | 0.00% |
| GTG Stock Forecast | Genetic Technologies | - |
0
|
$0.13 | Buy/Sell | $1.00 | -100.00% |
| OSL Stock Forecast | OncoSil Medical | - |
0
|
$0.01 | Buy/Sell | $0.11 | -100.00% |
.jpg)